Literature DB >> 6139454

Impairment of drug metabolism by the liver in experimental fascioliasis in the rat.

P Galtier, A Battaglia, J More, M Franc.   

Abstract

Fascioliasis has been produced in the rat by an oral administration of 20 metacercariae of Fasciola hepatica. Hepatic microsomal cytochrome P450 and b5 contents and both aminopyrine demethylase and aniline hydroxylase activities have been measured during the course of the experimental distomiasis. The cytochrome P450 concentration and microsomal drug metabolizing enzymes generally fell by weeks 3 to 8 post-infestation and recovered to normal values thereafter. For the same period, both the histoenzymatically assayed liver cytochrome oxidase and arylsulphatase activities were reduced whereas there were correlated increases in glutamic pyruvic and glutamic oxaloacetic plasma transaminases. Tissue inflammation and destruction provoked by young histophagous migrating flukes could be responsible for these changes that have already been observed in several hepatic diseases. The possible influence of naturally-induced fasciolasis on liver drug metabolism is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139454     DOI: 10.1111/j.2042-7158.1983.tb02879.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  The effect of Triaenophorus nodulosus (Cestoda: Bothriocephalidea) infection on some biochemical parameters of the liver of Perca fluviatilis.

Authors:  Ekaterina V Borvinskaya; Irina V Sukhovskaya; Lev P Smirnov; Albina A Kochneva; Aleksey N Parshukov; Marina Yu Krupnova; Elizaveta A Buoy; Rimma U Vysotskaya; Maria V Churova
Journal:  J Parasit Dis       Date:  2019-06-05

2.  Characterization of the Pathology, Biochemistry, and Immune Response in Kunming (KM) Mice Following Fasciola gigantica Infection.

Authors:  Xuefang Mei; Yaoyao Zhang; Chenyu Quan; Yiying Liang; Weiyi Huang; Wei Shi
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.